• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    GlaxoSmithKline Pharmaceuticals Limited — Board Meeting, 03-08-2026: Outcome of Board Meeting

    03-08-2026 | 04:05 pm

    GlaxoSmithKline Pharma's board approved Q1 financial results: consolidated revenue at Rs 938.44 Cr & profit at Rs 237.18 Cr (EPS Rs 14). Karine J F Natland joins as Non-Executive Director; Bhushan Akshikar re-appointed MD for two years.

    No comments yet. Be the first to comment!

    All announcements from GlaxoSmithKline Pharmaceuticals Limited